COMPANY PROFILE -Hikma Pharmaceuticals plc
Business Sector :Pharmaceuticals
Operating Geography :United Kingdom, Europe, Global
About Hikma Pharmaceuticals plc :
Hikma Pharmaceuticals plc is a non-branded generic and in-licensed pharmaceutical company headquartered in London, United Kingdom. In 1978, Samih Darwazah founded the company in Amman, Jordan. The company has 29 manufacturing facilities spread across 11 countries: the United States, Portugal, Italy, Jordan, Saudi Arabia, Algeria, Germany, Egypt, Morocco, Tunisia, and Sudan. It undertakes research and development in the areas such as cardiology, anti-infective, neurology, and dermatology. In the MENA region, Hikma's branded business segment consists of the development and sale of branded generics and in-licensed patented products. It offers 499 different medications in 1,256 different dosage strengths. Actos, Amoclan, Blopress, Omnicef, Prograf, and Suprax are some of the most popular products. Argatroban, fentanyl, phenylephrine, Robaxin, and iron gluconate are among the speciality injectable medications sold by Hikma in the United States, Europe, and MENA. As of early 2023, Hikma employed over 8,700 people.
Hikma Pharmaceutical's USP lies in its reputation for quality, high brand awareness, and FDA-inspected manufacturing facilities in the United States. The mission statement of Hikma Pharmaceuticals reads, "Improving lives' is Hikma's main mission, through providing high-quality affordable medication to patients and 'Improving lives' of its local communities and its employees".
Hikma Pharmaceuticals plc Revenue :
US$ 2,553 million - FY ending 31st December 2021
US$ 2,341 million - FY ending 31st December 2020
Competitive Analysis of Hikma Pharmaceuticals plc
The SWOT analysis for Hikma Pharmaceuticals plc is presented below in a matrix followed by the detailed analysis report:
Strengths | Weaknesses |
1. Strongly positioned to deliver sustainable growth
2. World-class infrastructure for generics development and manufacturing
3. Manufacturing flexibility can handle fluctuating demand
4. Continuous launch of new drugs
5. One of the largest pharmaceutical brands in MENA
6. Consistently maintained cash flow that supports R&D
| 1. Presence in few products categories |
Opportunities | Threats |
1. High demand for Covid-19 treatment drugs
2. Elective surgery products will see demand post covid
3. Biosimilar received a positive response in US
| 1. Emerging innovative sales channels increase competition
2. Reduced supply of APIs is inhibiting production
3. Patent infringement litigation with Amarin pharma
|
Hikma Pharmaceuticals plc SWOT and PESTLE Analysis PDF Report is a custom report and will be delivered to your email inbox within 2 business days from purchase.
Detailed SWOT Analysis of Hikma Pharmaceuticals plc
Strength
This section is available only in the 'Complete Report' on purchase.
Weakness
This section is available only in the 'Complete Report' on purchase.
Opportunity
1. High demand for Covid-19 treatment drugs: Pharmaceuticals industry saw a tectonic shift in demand towards drugs used for treatment of Covid-19 induced symptoms. Drugs such as Hydroxychloroquine, Ivermectin and Favipiravir were in massive demand across the globe. The international trade of these drugs and their APIs became a global political issue. Recently Remdesivir injections were in high demand for the treatment. Other than these, many pain, respiratory, sedative, and anesthetic drugs are seeing an exponential rise in demand. The other drugs that are required in curing of miscellaneous infectious diseases experienced subdued demand, as there was low occurrence of such diseases in social distancing environment and through lockdown phases. This trend is envisaged to continue until Covid-19 gets completely eradicated. Hikma ramped up its production to meet the demand for Covid related drugs. It also started manufacturing of Remdesivir. Hikma will continue to see success in launch of Covid-19 related drugs.
The remaining section under "Opportunity" is available only in the 'Complete Report' on purchase.
Threat
This section is available only in the 'Complete Report' on purchase.
The PESTLE analysis for Hikma Pharmaceuticals is presented below in a table followed by the detailed analysis report.
Political | Economical |
1. Governments focused on domestication of manufacturing
2. Brexit will result into increased operational restrictions
| 1. The global economic downturn has led to higher use of generics
2. Hyperinflationary conditions in Middle East will impact growth
|
Social | Technological |
1. Ageing population leads to increased healthcare spending | 1. Complex generics gaining prominence
2. Manufacturing 4.0 to revolutionize drug production
|
Legal | Environmental |
1. CFC rules to affect European subsidiaries | 1. Streamlined energy and carbon reporting framework will highlight energy usage
2. TCFD compliance ensures transparency of climate impact
|
Hikma Pharmaceuticals plc SWOT and PESTLE Analysis PDF Report is a custom report and will be delivered to your email inbox within 2 business days from purchase.
Detailed Pestle Analysis of Hikma Pharmaceuticals plc
Political
This section is available only in the 'Complete Report' on purchase.
Economic
This section is available only in the 'Complete Report' on purchase.
Social
1. Ageing population leads to increased healthcare spending: The world’s demographic trend indicates that the average age of the population is increasing. The total population is expected to increase by 2 billion by 2050. Currently 9% of the world population is above 65, which is estimated to go to 16% in 2050. So, the geriatric population is estimated to double over the years. This will result into increased instances of chronic non-communicable diseases such as diabetes, heart disease and cancer. In most cases older age itself is the cause for complications in a common disease. This will increase the demand for effective drugs. The other consequence of this trend is the taxing financial burden on healthcare systems. This will make the use of cost-effective drug therapies indispensable. Hikma Pharmaceuticals has diverse portfolio drugs that cater to chronic illnesses associated with age. Investments in research and development in this segment is necessary to become a market leader.
The remaining section under "Social" is available only in the 'Complete Report' on purchase.
Technological
This section is available only in the 'Complete Report' on purchase.
Legal
This section is available only in the 'Complete Report' on purchase.
Environmental
This section is available only in the 'Complete Report' on purchase.
Major Brands :
- Mitigare
- ADRIAMYCIN
- ALLOPURINOL
- AMIKACIN
- CISplatin
- DURAMORPH
- FLUMAZENIL
- IDARUBICIN
- Zortress
- PROPOFOL
Hikma Pharmaceuticals plc SWOT and PESTLE Analysis PDF Report is a custom report and will be delivered to your email inbox within 2 business days from purchase.
TABLE OF CONTENTS
DELIVERY AND FORMAT
WHY CHOOSE US?
You may also be interested in other analyses of Hikma Pharmaceuticals plc:
-
Hikma Pharmaceuticals plc Porter's Five Forces Analysis |
|
-
Hikma Pharmaceuticals plc VRIO Analysis |
|
-
Hikma Pharmaceuticals plc Value Chain Analysis |
|
-
Hikma Pharmaceuticals plc Covid-19 Impact Analysis |
|
-
Hikma Pharmaceuticals plc BCG Analysis |
|
-
Hikma Pharmaceuticals plc Segmentation, Targeting and Positioning (STP) Analysis |
|
-
Hikma Pharmaceuticals plc Ansoff Matrix Analysis |
|
Request for Quotation
Hikma Pharmaceuticals plc
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Company Overview Report
This report is shared in order to give you an idea of what the complete Company Overview Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Hikma Pharmaceuticals plc
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Competitor Analysis Report
This report is shared in order to give you an idea of what the complete Competitor Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Hikma Pharmaceuticals plc
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Porter's Five Forces Analysis Report
This report is shared in order to give you an idea of what the complete Porter's Five Forces Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Hikma Pharmaceuticals plc
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
VRIO Analysis Report
This report is shared in order to give you an idea of what the complete VRIO Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Hikma Pharmaceuticals plc
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Value Chain Analysis Report
This report is shared in order to give you an idea of what the complete Value Chain Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Hikma Pharmaceuticals plc
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Regulatory Outlook Report
This report is shared in order to give you an idea of what the complete Regulatory Outlook Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Hikma Pharmaceuticals plc
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Risk Analysis Report
This report is shared in order to give you an idea of what the complete Risk Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Hikma Pharmaceuticals plc
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Key Performance Indicators (KPI's) Report
This report is shared in order to give you an idea of what the complete Key Performance Indicators (KPI's) Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Hikma Pharmaceuticals plc
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Environmental, Social, and Governance (ESG) Analysis Report
This report is shared in order to give you an idea of what the complete Environmental, Social, and Governance (ESG) Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Hikma Pharmaceuticals plc
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
M&A Analysis Report
This report is shared in order to give you an idea of what the complete M&A Report and Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Hikma Pharmaceuticals plc
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Subsidiaries, Partnerships and Collaborations Report
This report is shared in order to give you an idea of what the complete Subsidiaries, Partnerships and Collaborations Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Hikma Pharmaceuticals plc
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Stakeholder Analysis Report
This report is shared in order to give you an idea of what the complete Stakeholder Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Hikma Pharmaceuticals plc
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Technology Landscape and Outlook Report
This report is shared in order to give you an idea of what the complete Technology Landscape and Outlook Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Hikma Pharmaceuticals plc
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Covid-19 Impact Analysis Report
This report is shared in order to give you an idea of what the complete Covid-19 Impact Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Hikma Pharmaceuticals plc
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Key News and Events Report
This report is shared in order to give you an idea of what the complete Key News and Events Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Hikma Pharmaceuticals plc
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
BCG Analysis Report
This report is shared in order to give you an idea of what the complete BCG Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Hikma Pharmaceuticals plc
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Digital Marketing and Social Media Strategy Analysis Report
This report is shared in order to give you an idea of what the complete Digital Marketing and Social Media Strategy Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Hikma Pharmaceuticals plc
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Segmentation, Targeting and Positioning (STP) Analysis Report
This report is shared in order to give you an idea of what the complete Segmentation, Targeting and Positioning (STP) Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
Hikma Pharmaceuticals plc
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Ansoff Matrix Analysis Report
This report is shared in order to give you an idea of what the complete Ansoff Matrix Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Check Out Analysis of Other Relevant Companies
References used in Hikma Pharmaceuticals plc SWOT & PESTLE Analysis Report
1. Annual Report - https://www.hikma.com/media/3129/hikma_ara_2021_full-interactive.pdf
2. Investors Presentation - https://www.hikma.com/media/3045/generics-mtm-presentation_v21-final.pdf
3. Covid-19 Created an Elective Surgery Backlog. How Can Hospitals Get Back on Track? - https://hbr.org/2020/08/covid-19-created-an-elective-surgery-backlog-how-can-hospitals-get-back-on-track
4. Amarin Files Patent Infringement Lawsuit Against Hikma - https://www.globenewswire.com/news-release/2020/12/01/2137000/0/en/Amarin-Files-Patent-Infringement-Lawsuit-Against-Hikma.html
The detailed complete set of references are available on request in the 'Complete report' on purchase.
How to Reference This Page?
You can use the following in your reference section in order to give credit to the source. For different referencing styles and detailed guidelines, please click here.
Hikma Pharmaceuticals plc SWOT and PESTLE Analysis - SWOT & PESTLE.COM
SWOT & PESTLE.com (2024). Hikma Pharmaceuticals plc SWOT and PESTLE Analysis - SWOT & PESTLE.com. [online] Available at: https://www.swotandpestle.com/hikma-pharmaceuticals/ [Accessed 03 Jul, 2024].
In-text: (SWOT & PESTLE.com, 2024)
Copyrights and Disclaimer
Hikma Pharmaceuticals plc SWOT and PESTLE analysis has been conducted by Mohit Harishchandra Deshmukh and reviewed by senior analysts from Barakaat Consulting.
Copyright of Hikma Pharmaceuticals plc SWOT and PESTLE Analysis is the property of Barakaat Consulting. Please refer to the Terms and Conditions and Disclaimer for usage guidelines.